[Current Data] Rule running report - 2024-06-28 07:49:01.864178

Nr2MedPage Today) -- A 15-day course of the antiviral nirmatrelvir-ritonavir (Paxlovid) didn't improve symptoms of long COVID, according to a randomized controlled trial that was stopped early for lack of… succesfully run! 0 Anläufe!